| Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 2.74 Billion | USD 4.32 Billion | 5.2% | 2024 |
FrequentlyAsked Questions
The global kidney stone management market is expected to grow due to rising prevalence of kidney stones, advancements in minimally invasive surgical technologies, increasing geriatric population, and growing demand for effective diagnostic and treatment solutions.
According to a study, the global kidney stone management market size was worth around USD 2.74 Billion in 2024 and is expected to reach USD 4.32 Billion by 2034.
The global kidney stone management market is expected to grow at a CAGR of 5.2% during the forecast period.
North America is expected to dominate the kidney stone management market over the forecast period.
Leading players in the global kidney stone management market include MorphoSys AG, Dyax Corp., Creative-biolabs, Abzena Plc., and AnaptysBio Inc Some of the other companies are Karl Storz GmbH & Co. Ltd., DirexGroup, Dornier MedTech, EDAP TMS, Lumenis Ltd., Elmed Medical System, Siemens Healthineers, Olympus Corporation, Cook Medical, Boston Scientific Corporation,, among others.
The report explores crucial aspects of the kidney stone management market, including a detailed discussion of existing growth factors and restraints, while also examining future growth opportunities and challenges that impact the market.
HappyClients